Advertisement

Related Videos

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Advertisement

Advertisement




Oct
29
Today In Oncology
Physician-Complementing Artificial Intelligence in Oncology
Zenocutuzumab Potential Explored in NRG1 Cholangiocarcinoma
Preneoplastic and Neoplastic Small Lymphocytic Proliferations
AI-Enhanced PACT as a Noninvasive Breast Imaging Alternative
Routine AI Assistance May Lead to Loss of Skills in Endoscopists, Study Shows
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo